With the advent of next-generation sequencing, we have an unprecedented ability to study
tumor and host genomes as well as those of the vast array of microorganisms that exist …

Although novel therapies, including immunotherapy, have dramatically improved outcomes
for many patients with cancer, overall outcomes are heterogeneous and existing biomarkers …

The relationship between gut microbiota and neurological diseases, including chronic pain,
has received increasing attention. The gut microbiome is a crucial modulator of visceral …

Fibromyalgia (FM) is a prevalent syndrome, characterised by chronic widespread pain,
fatigue, and impaired sleep, that is challenging to diagnose and difficult to treat. The …

Patients with chronic neuropathic pain frequently suffer from symptoms of anhedonia, which
is a core symptom of depression. Accumulating studies suggest that gut microbiota may play …

Chemotherapy induced peripheral neuropathy (CIPN), a toxic side effect of some cancer
treatments, negatively impacts patient outcomes and drastically reduces survivor's quality of …

An intricate relationship exists and interactions occur between gut microbiota and colorectal
cancer (CRC). Radical surgery combined with adjuvant chemotherapy (AC) serves as the …

Mounting evidence have demonstrated that gut microbiota plays a critical role in cancer
patients' therapeutic responses to chemotherapy, radiotherapy and immunotherapy …

Chemotherapy-induced peripheral neuropathy (CIPN) is a progressive, often irreversible
condition that produces severe neurological deficits. Emerging data suggest that …

Neuropathic pain is one of the most important types of chronic pain. It is caused by neuronal
damage. Clinical and experimental studies suggest a critical role for neuroimmune …